Page last updated: 2024-08-25

stearoyl alpha-lysolecithin and Diabetes Mellitus, Type 2

stearoyl alpha-lysolecithin has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higuchi, S; Ichikawa, K; Iida, M; Iino, K; Iwase, M; Ohdo, S; Sonoki, K; Yoshinari, M	1
Fujishima, M; Iwase, M; Shi, AH; Wakisaka, M; Yoshinari, M	1

Other Studies

2 other study(ies) available for stearoyl alpha-lysolecithin and Diabetes Mellitus, Type 2

Article	Year
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:3 Topics: Arteriosclerosis; Chemokine CCL2; Diabetes Mellitus, Type 2; DNA; Endothelium, Vascular; Gene Expression; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Phospholipases A; Phospholipases A2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Umbilical Veins	2003
Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1999, Volume: 31, Issue:4 Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Triglycerides	1999

Article

Year

Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.

Metabolism: clinical and experimental, 2003, Volume: 52, Issue:3

Topics: Arteriosclerosis; Chemokine CCL2; Diabetes Mellitus, Type 2; DNA; Endothelium, Vascular; Gene Expression; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Phospholipases A; Phospholipases A2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Umbilical Veins

2003

Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1999, Volume: 31, Issue:4

Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Triglycerides

1999